31. Mehler MF, Mattick JS. Noncoding RNAs and RNA editing in brain development, functional diversification and neurological disease. Physiol Rev 2007; 87:799- 823; PMID:17615389; http://dx.doi.org/10.1152/ physrev.00036.2006. 32. Mehler MF. Epigenetics and the nervous system. Ann Neurol 2008; 64:602-17; PMID:19107999; http:// dx.doi.org/10.1002/ana.21595. 33. Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS. Non-coding RNAs: regulators of disease. J Pathol 2010; 220:126-39; PMID:19882673; http://dx.doi. org/10.1002/path.2638. 34. Eacker SM, Dawson TM, Dawson VL. Understanding microRNAs in neurodegeneration. Nat Rev Neurosci 2009; 10:837-41; PMID:19904280; http://dx.doi. org/10.1038/nrn2726. 35. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011; 12:861-74; PMID:22094949; http:// dx.doi.org/10.1038/nrg3074. 36. Kosik KS. The neuronal microRNA system. Nat Rev Neurosci 2006; 7:911-20; PMID:17115073; http:// dx.doi.org/10.1038/nrn2037. 37. Miller BH, Wahlestedt C. MicroRNA dysregulation in psychiatric disease. Brain Res 2010; 1338:89- 99; PMID:20303342; http://dx.doi.org/10.1016/j. brainres.2010.03.035. 38. López Castel A, Cleary JD, Pearson CE. Repeat instability as the basis for human diseases and as a potential target for therapy. Nat Rev Mol Cell Biol 2010; 11:165-70; PMID:20177394; http://dx.doi. org/10.1038/nrm2854. 39. Mirkin SM. Expandable DNA repeats and human disease. Nature 2007; 447:932-40; PMID:17581576; http://dx.doi.org/10.1038/nature05977. 40. Moseley ML, Zu T, Ikeda Y, Gao W, Mosemiller AK, Daughters RS, et al. Bidirectional expression of CUG and CAG expansion transcripts and intranuclearpoly- glutamine inclusions in spinocerebellar ataxia type 8. Nat Genet 2006; 38:758-69; PMID:16804541; http:// dx.doi.org/10.1038/ng1827. 41. Cho DH, Thienes CP, Mahoney SE, Analau E, Filippova GN, Tapscott SJ. Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. Mol Cell 2005; 20:483-9; PMID:16285929; http://dx.doi.org/10.1016/j.mol- cel.2005.09.002. 42. David G, Abbas N, Stevanin G, Dürr A, Yvert G, Cancel G, et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet 1997; 17:65-70; PMID:9288099; http://dx.doi. org/10.1038/ng0997-65. 43. Lindblad K, Savontaus ML, Stevanin G, Holmberg M, Digre K, Zander C, et al. An expanded CAG repeat sequence in spinocerebellar ataxia type 7. Genome Res 1996; 6:965-71; PMID:8908515; http://dx.doi. org/10.1101/gr.6.10.965. 44. Sopher BL, Ladd PD, Pineda VV, Libby RT, Sunkin SM, Hurley JB, et al. CTCF regulates ataxin-7 expres- sion through promotion of a convergently transcribed, antisense noncoding RNA. Neuron 2011; 70:1071-84; PMID:21689595; http://dx.doi.org/10.1016/j.neu- ron.2011.05.027. 45. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, et al. High-resolution profiling of histone methylations in the human genome. Cell 2007; 129:823-37; PMID:17512414; http://dx.doi. org/10.1016/j.cell.2007.05.009. 46. Filippova GN. Genetics and epigenetics of the multifunctional protein CTCF. Curr Top Dev Biol 2008; 80:337-60; PMID:17950379; http://dx.doi. org/10.1016/S0070-2153(07)80009-3. 47. Daughters RS, Tuttle DL, Gao W, Ikeda Y, Moseley ML, Ebner TJ, et al. RNA gain-of-function in spino- cerebellar ataxia type 8. PLoS Genet 2009; 5:1000600; PMID:19680539; http://dx.doi.org/10.1371/journal. pgen.1000600. 48. Chen IC, Lin HY, Lee GC, Kao SH, Chen CM, Wu YR, et al. Spinocerebellar ataxia type 8 larger triplet expansion alters histone modification and induces RNA foci. BMC Mol Biol 2009; 10:9; PMID:19203395; http://dx.doi.org/10.1186/1471-2199-10-9. 49. Pearson CE, Nichol Edamura K, Cleary JD. Repeat instability: mechanisms of dynamic mutations. Nat Rev Genet 2005; 6:729-42; PMID:16205713; http:// dx.doi.org/10.1038/nrg1689. 50. Ohlsson R, Renkawitz R, Lobanenkov V. CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. Trends Genet 2001; 17:520-7; PMID:11525835; http://dx.doi.org/10.1016/S0168- 9525(01)02366-6. 51. Batra R, Charizanis K, Swanson MS. Partners in crime: bidirectional transcription in unstable micro- satellite disease. Hum Mol Genet 2010; 19:77-82; PMID:20368264; http://dx.doi.org/10.1093/hmg/ ddq132. 52. Clark AG, Glanowski S, Nielsen R, Thomas PD, Kejariwal A, Todd MA, et al. Inferring nonneutral evolution from human-chimp-mouse orthologous gene trios. Science 2003; 302:1960-3; PMID:14671302; http://dx.doi.org/10.1126/science.1088821. 53. Nielsen R. Molecular signatures of natu- ral selection. Annu Rev Genet 2005; 39:197-218; PMID:16285858; http://dx.doi.org/10.1146/annurev. genet.39.073003.112420. 54. Lander ES. Initial impact of the sequencing of the human genome. Nature 2011; 470:187-97; PMID:21307931; http://dx.doi.org/10.1038/nature09792. 55. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, Rosenbloom K, et al. Evolutionarily conserved ele- ments in vertebrate, insect, worm and yeast genomes. Genome Res 2005; 15:1034-50; PMID:16024819; http://dx.doi.org/10.1101/gr.3715005. 56. Zuccato C, Cattaneo E. Role of brain-derived neuro- trophic factor in Huntington’s disease. ProgNeurobiol 2007; 81:294-330; PMID:17379385; http://dx.doi. org/10.1016/j.pneurobio.2007.01.003. 57. Johnson DS, Mortazavi A, Myers RM, Wold B. Genome-wide mapping of in vivo protein-DNA interac- tions. Science 2007; 316:1497-502; PMID:17540862; http://dx.doi.org/10.1126/science.1141319. 58. Fowden AL, Sibley C, Reik W, Constancia M. Imprinted genes, placental development and fetal growth. Horm Res 2006; 65:50-8; PMID:16612114; http://dx.doi.org/10.1159/000091506. 59. Davies W, Isles AR, Wilkinson LS. Imprinted gene expression in the brain. Neurosci Biobehav Rev 2005; 29:421-30; PMID:15820547; http://dx.doi. org/10.1016/j.neubiorev.2004.11.007. 60. Wilkinson LS, Davies W, Isles AR. Genomic imprint- ing effects on brain development and function. Nat Rev Neurosci 2007; 8:832-43; PMID:17925812; http:// dx.doi.org/10.1038/nrn2235. 61. Schulze TG, Buervenich S, Badner JA, Steele CJ, Detera-Wadleigh SD, Dick D, et al. Loci on chro- mosomes 6q and 6p interact to increase susceptibility to bipolar affective disorder in the national institute of mental health genetics initiative pedigrees. Biol Psychiatry 2004; 56:18-23; PMID:15219468; http:// dx.doi.org/10.1016/j.biopsych.2004.04.004. 62. Schanen NC. Epigenetics of autism spectrum disorders. Hum Mol Genet 2006; 15:138-50; PMID:16987877; http://dx.doi.org/10.1093/hmg/ddl213. 63. Francks C, DeLisi LE, Shaw SH, Fisher SE, Richardson AJ, Stein JF, et al. Parent-of-origin effects on hand- edness and schizophrenia susceptibility on chromo- some 2p12-q11. Hum Mol Genet 2003; 12:3225-30; PMID:14583442; http://dx.doi.org/10.1093/hmg/ ddg362. 64. Katayama S, Tomaru Y, Kasukawa T, Waki K, Nakanishi M, Nakamura M, et al.; RIKEN Genome Exploration Research Group; Genome Science Group (Genome Network Project Core Group); FANTOM Consortium. Antisense transcription in the mam- malian transcriptome. Science 2005; 309:1564-6; PMID:16141073; http://dx.doi.org/10.1126/sci- ence.1112009. 65. Chamberlain SJ, Lalande M. Angelman syndrome, a genomic imprinting disorder of the brain. J Neurosci 2010; 30:9958-63; PMID:20668179; http://dx.doi. org/10.1523/JNEUROSCI.1728-10.2010. 66. Yamasaki K, Joh K, Ohta T, Masuzaki H, Ishimaru T, Mukai T, et al. Neurons but not glial cells show reciprocal imprinting of sense and antisense tran- scripts of Ube3a. Hum Mol Genet 2003; 12:837-47; PMID:12668607; http://dx.doi.org/10.1093/hmg/ ddg106. 67. Kishino T, Lalande M, Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet 1997; 15:70-3; PMID:8988171; http://dx.doi.org/10.1038/ ng0197-70. 68. Matsuura T, Sutcliffe JS, Fang P, Galjaard RJ, Jiang YH, Benton CS, et al. De novo truncating muta- tions in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet 1997; 15:74-7; PMID:8988172; http://dx.doi.org/10.1038/ng0197- 74. 69. Huang HS, Allen JA, Mabb AM, King IF, Miriyala J, Taylor-Blake B, et al. Topoisomerase inhibitors unsi- lence the dormant allele of Ube3a in neurons. Nature 2011; 481:185-9; PMID:22190039; http://dx.doi. org/10.1038/nature10726. 70. Modarresi F, Faghihi MA, Patel NS, Sahagan BG, Wahlestedt C, Lopez-Toledano MA. Knockdown of BACE1-AS Nonprotein-Coding Transcript Modulates Beta-Amyloid-Related Hippocampal Neurogenesis. Int J Alzheimers Dis 2011; 2011:929042; PMID:21785702. 71. Engström PG, Suzuki H, Ninomiya N, Akalin A, Sessa L, Lavorgna G, et al. Complex Loci in human and mouse genomes. PLoS Genet 2006; 2:47; PMID:16683030; http://dx.doi.org/10.1371/journal. pgen.0020047. 72. Vincent JB, Petek E, Thevarkunnel S, Kolozsvari D, Cheung J, Patel M, et al. The RAY1/ST7 tumor-sup- pressor locus on chromosome 7q31 represents a com- plex multi-transcript system. Genomics 2002; 80:283- 94; PMID:12213198; http://dx.doi.org/10.1006/ geno.2002.6835. 73. Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CA, et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 2000; 9:1415-23; PMID:10814723; http://dx.doi.org/10.1093/ hmg/9.9.1415. 74. Blackwood DH, Fordyce A, Walker MT, St. Clair DM, Porteous DJ, Muir WJ. Schizophrenia and affective dis- orders—cosegregation with a translocation at chromo- some 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet 2001; 69:428-33; PMID:11443544; http:// dx.doi.org/10.1086/321969. 75. Sokolov BP, Polesskaya OO, Uhl GR. Mouse brain gene expression changes after acute and chronic amphetamine. J Neurochem 2003; 84:244-52; PMID:12558987; http://dx.doi.org/10.1046/j.1471- 4159.2003.01523.x. 76. Bond AM, Vangompel MJ, Sametsky EA, Clark MF, Savage JC, Disterhoft JF, et al. Balanced gene regula- tion by an embryonic brain ncRNA is critical for adult hippocampal GABA circuitry. Nat Neurosci 2009; 12:1020-7; PMID:19620975; http://dx.doi. org/10.1038/nn.2371. 77. Di Cristo G, Pizzorusso T, Cancedda L, Sernagor E. GABAergic circuit development and its impli- cation for CNS disorders. Neural Plast 2011; 2011:623705; PMID:22013542; http://dx.doi. org/10.1155/2011/623705. 868 rNA Biology volume 9 issue 6